EMA Approves Lower GWP Alternative for Inhalation Medicine
EUROPEAN UNION, JUL 25 – The European Medicines Agency backs an inhaler that reduces NHS carbon emissions by 3%, using a low-impact propellant to lower healthcare's climate footprint, AstraZeneca said.
Summary by pharmtech.com
4 Articles
4 Articles
EMA Approves Propellant with 1000-Fold Lower Global Warming Potential for Trixeo and Riltrava Aerosphere
The European Medicines Agency (EMA) has issued a positi […] The post EMA Approves Propellant with 1000-Fold Lower Global Warming Potential for Trixeo and Riltrava Aerosphere first appeared on GeneOnline News. The post EMA Approves Propellant with 1000-Fold Lower Global Warming Potential for Trixeo and Riltrava Aerosphere appeared first on GeneOnline News.
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium